Parkinson's disease and Alzheimer's disease are both types of neurodegenerative conditions, yet they exhibit distinct symptoms and mechanisms. Parkinson's predominantly impacts movement, causing symptoms like tremors, stiffness, and impaired balance, resulting from the loss of dopamine-producing neurons. On the other hand, Alzheimer's primarily affects memory, cognition, and behavior due to the accumulation of plaques and tangles in the brain.
These diseases differ not only in their symptoms but also in their affected brain regions and progression patterns. Parkinson's initially manifests with motor impairments, while Alzheimer's typically starts with memory and cognitive decline. Recognizing these distinctions is crucial for accurate diagnosis and effective treatment planning tailored to each condition's specific challenges. Early diagnosis and appropriate management strategies can significantly enhance patients' quality of life and potentially slow disease progression in both cases.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States